Bifurcation stenting: current strategies and new devices

被引:81
作者
Latib, A. [2 ,3 ]
Colombo, A. [1 ,2 ]
Sangiorgi, G. M. [1 ,2 ]
机构
[1] EMO Ctr Cuore Columbus, Intervent Cardiol Unit, I-20145 Milan, Italy
[2] Ist Sci San Raffaele, Intervent Cardiol Unit, I-20132 Milan, Italy
[3] Univ Cape Town, Dept Med, Div Cardiol, ZA-7925 Cape Town, South Africa
关键词
ELUTING STENTS; CORONARY LESIONS; FOLLOW-UP; DISEASE;
D O I
10.1136/hrt.2008.150391
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Based on the results of numerous randomised trials, the provisional approach of implanting one stent on the main branch has become the default approach to most bifurcation lesions. However, bifurcation intervention still remains technically challenging. Dedicated bifurcation stents have been designed to specifically treat coronary bifurcations with the aim of dealing with some of the shortcomings of the conventional percutaneous approach to bifurcation intervention. Most of the devices are aimed at facilitating the provisional approach. They are an exciting and innovative technology that may further simplify the management and current approach to bifurcation treatment. Currently, 11 devices are available that have either completed or are currently undergoing First-In-Man trials. The development of more drug-eluting platforms and larger studies with control groups demonstrating their clinical applicability, efficacy and safety are required before they are widely incorporated into daily practice.
引用
收藏
页码:495 / 504
页数:10
相关论文
共 28 条
[1]  
Abizaid Alexandre, 2007, EuroIntervention, V2, P518
[2]   Randomized study to evaluate sirolimus-eluting stents implanted at coronary bifurcation lesions [J].
Colombo, A ;
Moses, JW ;
Morice, MC ;
Ludwig, J ;
Holmes, DR ;
Spanos, V ;
Louvard, Y ;
Desmedt, B ;
Di Mario, C ;
Leon, MB .
CIRCULATION, 2004, 109 (10) :1244-1249
[3]  
COLOMBO A, 2008, EUROPCR 2008 BARC SP
[4]  
COSTA RA, 2008, J AM COLL CARDIOL, V51, pB51
[5]  
FERENC M, 2008, EUR HEART J 1009
[6]   Treatment of bifurcation lesions with two stents: one year angiographic and clinical follow up of crush versus T stenting [J].
Ge, L ;
Iakovou, I ;
Cosgrave, J ;
Agostoni, P ;
Airoldi, F ;
Sangiorgi, GM ;
Michev, I ;
Chieffo, A ;
Montorfano, M ;
Carlino, N ;
Corvaja, N ;
Colombo, A .
HEART, 2006, 92 (03) :371-376
[7]   In-hospital and nine-month outcome of treatment of coronary bifurcational lesions with sirolimus-eluting stent [J].
Ge, L ;
Tsagalou, E ;
Iakovou, I ;
Sangiorgi, GM ;
Corvaja, N ;
Airoldi, F ;
Chieffo, A ;
Montorfano, M ;
Michev, I ;
Colombo, A .
AMERICAN JOURNAL OF CARDIOLOGY, 2005, 95 (06) :757-760
[8]  
GRUBE E, 2007, TRANSC CARD THER TCT
[9]  
GRUBE E, 2008, EUROPCR 2008 BARC SP
[10]   Six-month clinical and angiographic results of a dedicated drug-eluting Stent for the treatment of coronary bifurcation narrowings [J].
Grube, Eberhard ;
Buellesfeld, Lutz ;
Neumann, Franz J. ;
Verheye, Stefan ;
Abizaid, Alexandre ;
McClean, Dougal ;
Mueller, Ralf ;
Lansky, Alexandra ;
Mehran, Roxana ;
Costa, Ricardo ;
Gerckens, Ulrich ;
Trauthen, Brett ;
Fitzgerald, Peter J. .
AMERICAN JOURNAL OF CARDIOLOGY, 2007, 99 (12) :1691-1697